Tvardi Therapeutics, Inc. Income Statement

Income Statement Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 1.19M11.96M3.18M3.80M0.09M
Gross Profit 1.19M11.96M3.18M3.80M0.09M
Operating items
Research & Development 4.60M8.69M15.07M21.22M49.25M
Selling, General & Administrative 2.83M3.52M6.18M7.77M9.23M
Operating Expenses 7.43M12.20M21.25M28.99M58.49M
Operating Income -6.24M-0.24M-18.07M-25.19M-58.40M
EBIT -6.24M-0.24M-18.07M-25.19M-58.40M
Non-operating items
Interest & Investment Income -0.07M-3.76M0.13M
Other Non Operating Income -3.76M0.13M0.10M0.65M
Non Operating Income -3.76M0.13M0.10M0.65M
Net income details
EBT -6.30M-3.99M-17.95M-25.09M-57.75M
Tax Provisions -0.03M-0.03M-0.20M-0.40M-0.47M
Profit After Tax -6.27M-3.96M-17.75M-24.69M-57.28M
Income from Continuing Operations -6.27M-3.96M-17.75M-24.69M-57.28M
Consolidated Net Income -6.27M-3.96M-17.75M-24.69M-57.28M
Income towards Parent Company -6.27M-3.96M-17.75M-24.69M-57.28M
Net Income towards Common Stockholders -6.27M-3.96M-17.75M-24.69M-57.28M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.61M0.63M0.76M0.76M0.91M1.10M1.30M1.38M1.48M1.49M1.51M1.52M
EBITDA -6.24M-3.07M-17.75M-24.73M-57.24M
Tax Rate 0.49%0.75%1.12%1.58%0.81%